Pakistan’s pharmaceutical exports are presently over $ 800 million, annually, expected to touch $ 2000 million mark by 2018.
Member Senate Standing Committee on National Health Services, Regulations and Coordination, Senator Abdul Haseeb Khan, said this while talking to media at Karachi Press Club on Thursday.
He said existing laws be strictly implemented in letter and spirit to check and eliminate manufacturing and sale of spurious and substandard drugs in the country.
He recalled that he himself was one of the creators of Drug Regulatory Authority Pakistan (DRAP), Act 2012.
The law on Drugs of 1976 was very simple, but improvement was being brought in it gradually, he added. He said all drugs manufacturers were requested to provide the lists of their products, so as to enlist the same, in the legislation process.
Bringing improvement in the laws enacted on drugs, was underway, and opinions of all stakeholders will also be incorporated in this regard, he added. Senator Abdul Haseeb Khan, who is also chairman of a private pharmaceutical company, called for need to implement the law to curb drugs counterfeiting and sale and manufacturing of sub-standard drugs.
He told a questioner that unethical marketing practices were being used by different pharmaceutical companies in Pakistan which was needed to be checked.